Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.
about
A review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital Chlamydia infectionAdvances in HIV microbicide developmentThe Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal MucosaThe regulation of inflammatory pathways and infectious disease of the cervix by seminal fluidHIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIVImmune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection.The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.Immune cells in the female reproductive tractThe Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cellsPharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infectionCellular superspreaders: an epidemiological perspective on HIV infection inside the bodyProgestin-Containing Contraceptives Alter Expression of Host Defense-Related Genes of the Endometrium and CervixPotential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection.Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulationSafety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid.Caveats associated with the use of human cervical tissue for HIV and microbicide research.Targeting Trojan Horse leukocytes for HIV prevention.A comparative analysis of gene expression patterns and cell phenotypes between cervical and peripheral blood mononuclear cells.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.The structure of the human vaginal stratum corneum and its role in immune defensePPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infectionThe injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.Candida infections of the genitourinary tract.Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility.Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men.Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection.In situ distribution of HIV-binding CCR5 and C-type lectin receptors in the human endocervical mucosa.Cervical and vaginal flora specimens are highly concordant with respect to bacterial vaginosis-associated organisms and commensal Lactobacillus species in women of reproductive age.Methylation patterns of the IFN-γ gene in cervical cancer tissues.Mucosal immunity in the female genital tract, HIV/AIDSInnate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.Blunted IL17/IL22 and pro-inflammatory cytokine responses in the genital tract and blood of HIV-exposed, seronegative female sex workers in KenyaDecreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safetyHow can we design better vaccines to prevent HIV infection in women?Preclinical evaluation of the immunomodulatory lymphocyte trafficking drug FTY720 for HIV prevention in the female genital mucosa of macaquesChanges in genital tract immune cell populations after initiation of intrauterine contraception.Blocking of integrins inhibits HIV-1 infection of human cervical mucosa immune cells with free and complement-opsonized virions.
P2860
Q26786555-DCE92B5D-5216-4252-967A-5A77B57DB49EQ26852858-9938A56C-4209-48EE-8AFF-65183A7729B9Q27000032-B8B50C4A-2B20-4E8D-9762-5D9B9642B9C4Q27024447-6FBD4DDB-05C2-412E-9AA8-695B8C49C0C9Q27497560-124E0CC1-B220-4581-84D6-B69895CE54FCQ27692578-3EBA6D9C-3FBA-4C80-B8C2-E931C3C483DFQ27692596-9E1FBE55-5A73-45AA-8B04-969BD9A3FF54Q28086783-5FBDAC5B-F673-4F79-A476-C4C8FD61D293Q28302792-73EA2A88-0969-4FB3-9FBB-6872FD6A351DQ28481276-CD15EBBA-2958-4FD9-BAFA-85340325F6DEQ28657772-0E4CC375-5D7A-413A-B271-8D7393F7CC50Q30358037-C14ACD55-C204-4326-A981-0D8EEE117E04Q30413754-2A8B0FAA-96B5-41B9-A0F6-7D65C2885AD4Q30447923-9F6C0D4B-7F55-494A-B87F-53910EFDE205Q33390770-66558BCC-5798-4A03-8ECC-0BA29CA861EDQ33399887-EFF38643-8A11-457C-B362-043F38E4787AQ33515006-6DF562A3-2879-44A0-852C-34436B8405A0Q33518390-B1953BAE-712A-4545-BED7-35BA83137C76Q33518544-33F65C89-2537-40CE-A254-419CE0A7ABD2Q33611645-95F8FF3D-D695-4DF3-9546-F10A2672FBECQ33624947-3FD36ABC-677C-4460-8318-40A3ECBB27F6Q33628817-0D2941EA-F26D-4F01-A77C-04186B886DD9Q33631772-ACF1BD36-8E02-46F8-B184-D4F7CF77BAF2Q33753950-B835A53B-6EC4-44E9-9B78-F5B7D620DFEDQ33825621-C5BC64A3-A1C8-42BD-9911-A72E2C734C2BQ33870365-51CAA6EF-A09B-4A62-BB8D-3FDA02C5877FQ33882463-EE9B3CC9-BE7D-4AE0-BE39-406404C89BFCQ33954795-EF811428-08CA-4506-9829-A5253A5630D6Q34044944-53603998-77B0-4A4C-A590-CD48E40C280FQ34058725-A5B2E731-4D8F-47E4-91D4-2C5ABF4A213FQ34162497-212AD219-CDC3-4114-8167-B5436429519EQ34275424-82353820-4651-4FD6-A49E-4EF0AEC3D54BQ34339797-0B241A21-F423-4CD8-A9CE-D12ECC35568FQ34345929-AD75738F-A316-4677-BC26-A1B9DBCF207DQ34395906-38DA8EF8-1B7B-40C1-B59D-C07D31226804Q34425552-2809A0A0-2BEF-4C2F-ABF2-D38BA6A22564Q34449068-346EF6D3-D61E-4297-A952-4A8DC7595064Q34478248-3A2532B7-80C1-4F3B-9101-6F4F5E80ABB7Q34506212-1A00161A-F2E7-4FCF-87B8-61392D8EAAE2Q34507239-4C4B615A-F8F8-4D43-9E42-DFC9F6242F32
P2860
Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Immunological microenvironment ...... cervical transformation zone.
@ast
Immunological microenvironment ...... cervical transformation zone.
@en
type
label
Immunological microenvironment ...... cervical transformation zone.
@ast
Immunological microenvironment ...... cervical transformation zone.
@en
prefLabel
Immunological microenvironment ...... cervical transformation zone.
@ast
Immunological microenvironment ...... cervical transformation zone.
@en
P2860
P1476
Immunological microenvironment ...... cervical transformation zone.
@en
P2093
Alison J Quayle
Deborah J Anderson
P2860
P304
P356
10.1095/BIOLREPROD.105.043133
P407
P577
2005-08-10T00:00:00Z